Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Combination of pegcrisantaspase and venetoclax in acute myeloid leukaemia

Dr Ashkan Emadi - University of Maryland Medical Centre, Maryland, USA
Combination of pegcrisantaspase and venetoclax in acute myeloid leukaemia ( Dr Ashkan Emadi - University of Maryland Medical Centre, Maryland, USA )
20 Jun 2019

Using bioinformatics and genomics to treat AML

Prof Torsten Haferlach - MLL Münchner Leukämielabor GmbH, Munich, Germany
Using bioinformatics and genomics to treat AML ( Prof Torsten Haferlach - MLL Münchner Leukämielabor GmbH, Munich, Germany )
20 Jun 2019

MOR208 plus lenalidomide in r-r diffuse large B-cell lymphoma

Dr Johannes Düll - University of Würzburg, Würzburg, Germany
MOR208 plus lenalidomide in r-r diffuse large B-cell lymphoma ( Dr Johannes Düll - University of Würzburg, Würzburg, Germany )
20 Jun 2019

CLL14: A chemotherapy-free regimen of venetoclax plus obinutuzumab for CLL

Dr Othman Al-Sawaf - Univesity of Cologne, Cologne, Germany
CLL14: A chemotherapy-free regimen of venetoclax plus obinutuzumab for CLL ( Dr Othman Al-Sawaf - Univesity of Cologne, Cologne, Germany )
20 Jun 2019

Cancer care in Latin America

Dr Jean Rene Clemenceau - Hospital Angeles del Pedregal, Mexico City, Mexico
Cancer care in Latin America ( Dr Jean Rene Clemenceau - Hospital Angeles del Pedregal, Mexico City, Mexico )
18 Jun 2019

Challenges in global cancer control

Prof Mary Gospodarowicz - University Health Network, Toronto, Canada
Challenges in global cancer control ( Prof Mary Gospodarowicz - University Health Network, Toronto, Canada )
18 Jun 2019

Venetoclax with bortezomib and dexamethasone shows good response but higher risk of treatment related death in RRMM

Dr Shaji Kumar - Mayo Clinic, Rochester, USA
Venetoclax with bortezomib and dexamethasone shows good response but higher risk of treatment related death in RRMM ( Dr Shaji Kumar - Mayo Clinic, Rochester, USA )
15 Jun 2019

CALGB 90601: Comparing gemcitabine and cisplatin with bevacizumab to placebo for metastatic urothelial carcinoma

Dr Jonathan Rosenberg - Memorial Sloan-Kettering Cancer Institute, New York, USA
CALGB 90601: Comparing gemcitabine and cisplatin with bevacizumab to placebo for metastatic urothelial carcinoma ( Dr Jonathan Rosenberg - Memorial Sloan-Kettering Cancer Institute, New York, USA )
13 Jun 2019

Comment: Chemotherapy for frail and elderly patients with advanced gastroesophageal cancer

Prof Heinz-Josef Lenz - USC Norris Comprehensive Cancer Center, Los Angeles, USA
Comment: Chemotherapy for frail and elderly patients with advanced gastroesophageal cancer ( Prof Heinz-Josef Lenz - USC Norris Comprehensive Cancer Center, Los Angeles, USA )
13 Jun 2019

ASCO 2019 and vision for cancer control

Dr Eduardo Cazap - Editor-in-Chief, ecancer
ASCO 2019 and vision for cancer control ( Dr Eduardo Cazap - Editor-in-Chief, ecancer )
11 Jun 2019

Better education about breast cancer treatment in Africa

Dr Beatrice Wiafe-Addai - Peace And Love Hospital Breast care International, Accra, Ghana
Better education about breast cancer treatment in Africa ( Dr Beatrice Wiafe-Addai - Peace And Love Hospital Breast care International, Accra, Ghana )
5 Jun 2019

A severe lack of cancer care in Burundi

Dr Canesius Uwizeyimana - Radiation Oncology Medical Physicist, Bujumbura, Burundi
A severe lack of cancer care in Burundi ( Dr Canesius Uwizeyimana - Radiation Oncology Medical Physicist, Bujumbura, Burundi )
5 Jun 2019